Brian L Bray

USPTO Granted Patents = 13 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 119(Granted Patents)

Company Filing History:

5. 1 out of 832,680

Other

patents

Years Active: 1991-2011

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8034899 - HIV fusion inhibitor peptides with improved biological properties (2011-10-11),

2. 7556813 - Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides (2009-07-07),

3. 7456251 - HIV fusion inhibitor peptides with improved biological properties (2008-11-25),

4. 7045552 - Pharmaceutical composition for improved administration of HIV gp41-derived peptides, and its use in therapy (2006-05-16),

5. 6767993 - Methods and compositions for peptide synthesis (2004-07-27),

6. 6469136 - Methods and composition for peptide synthesis (2002-10-22),

7. 6281331 - Methods and compositions for peptide synthesis (2001-08-28),

8. 6015881 - Methods and compositions for peptide synthesis (2000-01-18),

9. 5576430 - 1,8-diazabicyclo[5.4.0]undec-1(7)-enium cyanide and method of making (1996-11-19),

10. 5438132 - Method for removing osmium from nucleosides (1995-08-01),

11. 5329008 - Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone (1994-07-12),

12. 5233041 - Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone from a (1993-08-03),

13. 5053338 - Kinetic resolution of pyridazinones using lipase (1991-10-01),

Title: **Inventor Spotlight: Brian L. Bray**

Introduction

Brian L. Bray, hailing from Graham, North Carolina, has made significant contributions to the field of biomedical research through his innovative inventions. With a remarkable portfolio of 13 patents, he has focused his work on developing novel antiviral therapies that have the potential to address critical health issues.

Latest Patents

Among his latest innovations, Bray is known for his work on HIV fusion inhibitor peptides that exhibit improved biological properties. Specifically, his patented HIV fusion inhibitor peptide features various amino acid sequences, provided in the form of pharmaceutical compositions combined with acceptable carriers. This advancement offers new methods of treatment for HIV infections. Additionally, Bray has developed antiviral peptide-polymer conjugates that incorporate synthetic HIV gp41 peptides, designed to inhibit the transmission of HIV to target cells. These conjugates facilitate an effective response against the virus, showcasing Bray's dedication to combating one of the most pressing health challenges of our time.

Career Highlights

During his career, Brian L. Bray has worked with several notable companies in the pharmaceutical sector, including Trimeris, Inc. and Glaxo Inc., where he has leveraged his expertise to advance HIV research and develop groundbreaking treatments. His innovative spirit and commitment to improving public health have made him a distinguished figure in medical innovation.

Collaborations

Throughout his career, Bray has worked alongside esteemed colleagues such as Myung-Chol Kang and John Joseph Partridge. These collaborative efforts have enhanced his research and fostered a dynamic exchange of ideas, further fueling the advancements in antiviral therapies.

Conclusion

Brian L. Bray stands out as an influential inventor and researcher in the realm of HIV treatment, with a portfolio that reflects his dedication to medical science. His patents not only demonstrate his innovative mindset but also hold the potential for significant societal impact. As research continues to evolve, Bray's contributions will undoubtedly play a crucial role in the ongoing battle against viral infections.

This text is generated by artificial intelligence and may not be accurate.